Wang et al. conducted a correlation analysis of clinicopathological variables on MyD88 expression in colorectal cancer and found that high expression of MyD88 was significantly correlated with disease-free survival and overall survival (HR: 2.33; 95% CI: 1.31–4.13; p = 0.0038, HR: 3.03; 95% CI: 1.67–5.48; p = 0.0002). This evidence concerns the gene MYD88 and colorectal cancer.